AMAG Pharmaceuticals manufactures and markets Feraheme® to treat iron deficiency anemia in patients with adult chronic kidney disease. In 2009, the U.S. Food and Drug Association awarded AMAG Pharmaceuticals marketing approval for Feraheme. The company commercially launched Feraheme in the U.S. shortly thereafter. For more information visit the company’s Web site at www.amagpharma.com
ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: